Show simple item record

Pulmonary delivery of inhalable nanoparticles: Dry powder inhalers

dc.contributor.authorAl-Hallak, MK
dc.contributor.authorSarfraz, MK
dc.contributor.authorAzarmi, S
dc.contributor.authorRoa, WH
dc.contributor.authorFinlay, WH
dc.contributor.authorL?benberg, R
dc.date.accessioned2018-08-26T09:33:07Z
dc.date.available2018-08-26T09:33:07Z
dc.date.issued2011
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/57490
dc.description.abstractPulmonary administration of inhalable nanoparticles (NPs) is an emerging area of interest. Dry powder inhalers may offer particular advantages for pulmonary administration of NPs. This article reviews research performed on the formulation of inhalable NPs as dry powder to achieve deep-lung deposition and enhance NP redispersibility. Moreover, the article summarizes up-to-date in vivo applications of inhalable NPs as dry powder inhalers. é 2011 Future Science Ltd.
dc.language.isoEnglish
dc.relation.ispartofTherapeutic Delivery
dc.subject6 [2 (dimethylamino)ethylamino] 3 hydroxy 7h indeno[2,1 c]quinolin 7 one
dc.subjectbudesonide
dc.subjectchitosan
dc.subjectciprofloxacin
dc.subjectdiatrizoate
dc.subjectdiphtheria toxoid CRM197
dc.subjectexcipient
dc.subjectgelatin
dc.subjecthepatitis B surface antigen
dc.subjecthonokiol
dc.subjectinsulin
dc.subjectleucine
dc.subjectmacrogol
dc.subjectmannitol
dc.subjectnanoaggregate
dc.subjectnanocomposite
dc.subjectnanomaterial
dc.subjectnanoparticle
dc.subjectnifedipine
dc.subjectpaclitaxel
dc.subjectpolycaprolactone
dc.subjectpolyglactin
dc.subjectpolyvinyl alcohol
dc.subjectpranlukast
dc.subjectrifampicin
dc.subjectsodium chloride
dc.subjectsolid lipid nanoparticle
dc.subjectthymopentin
dc.subjectTrojan particle
dc.subjectunclassified drug
dc.subjectunindexed drug
dc.subjectarea under the curve
dc.subjectasthma
dc.subjectchemical procedures
dc.subjectcolloid
dc.subjectdispersion
dc.subjectdrug absorption
dc.subjectdrug bioavailability
dc.subjectdrug blood level
dc.subjectdrug delivery system
dc.subjectdrug formulation
dc.subjectdry powder
dc.subjectflocculation
dc.subjecthuman
dc.subjectlung cancer
dc.subjectmetered dose inhaler
dc.subjectnebulizer
dc.subjectnonhuman
dc.subjectpowder inhaler
dc.subjectpriority journal
dc.subjectreview
dc.subjectspray drying
dc.subjectspray freeze drying
dc.subjectultrasound
dc.subjectAdministration, Inhalation
dc.subjectAnimals
dc.subjectDrug Delivery Systems
dc.subjectDry Powder Inhalers
dc.subjectEquipment Design
dc.subjectHumans
dc.subjectLung
dc.subjectNanoparticles
dc.subjectPharmaceutical Preparations
dc.subjectTissue Distribution
dc.titlePulmonary delivery of inhalable nanoparticles: Dry powder inhalers
dc.typeArticle
dc.citation.volume2
dc.citation.issue10
dc.citation.spage1313
dc.citation.epage1324
dc.citation.indexScopus
dc.identifier.DOIhttps://doi.org/10.4155/tde.11.100


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record